See also this year's filing and all EDGAR filings for this company.
PDF Report 0001434647_2017_ZEVRA_THERAPEUTICS_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| warning | Expenses in unusual place in relation to revenue | input.sec.calculation_linkbase.edgar_model_mapping | {'expenses_node': 'OperatingExpenses', 'revenue_node': 'SalesRevenueNet', 'net_inc_node': 'NetIncomeLoss'} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.08033736354658766, 'aggregate_val': 40477000, 'exp_sum': 37467000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 14000000, 'ResearchAndDevelopmentExpense': 20472000, 'remainder_Expenses': 2995000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001434647')"} |
Graph
Absolute values for 0001434647, ZEVRA THERAPEUTICS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 74,357,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,970,000 |
| 3 | remainder_Assets | 8,560,000 |
| 4 | LiabilitiesCurrent | 6,642,000 |
| 5 | LiabilitiesNoncurrent | 1,153,000 |
| 6 | remainder_Liabilities | 95,788,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,000,000 |
| 9 | ResearchAndDevelopmentExpense | 20,472,000 |
| 10 | remainder_Expenses | 6,005,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 20,951,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 84,887,000 |
| 1 | Liabilities | 103,583,000 |
| 2 | Expenses | 40,477,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -18,696,000 |
| 5 | NetIncome | -19,526,000 |
| 6 | ComprehensiveNetIncome | -19,526,000 |
| 7 | BaseVar | 124,949,000 |
| 8 | EconomicCapitalRatio | -0.548 |
Edgar->Model Mapping
Feature Distribution
